FIELD: medicine.
SUBSTANCE: invention may be used to reduce a risk of damaging cell membranes of the foetoplacental organs in the third trimester of gestation with aggravated herpes virus infection in the 12th week of gestation. That is ensured by an intravenous drop-by-drop infusion of human immunoglobulin 25 drops in the 16th and 24th weeks of pregnancy three times every second day.
EFFECT: method enables preventing damaging the cell membranes of the foetoplacental organs by reducing the fatty acid peroxide content in peripheral blood.
Authors
Dates
2014-05-27—Published
2012-11-22—Filed